Rescue of respiratory and cognitive impairments in Rett Syndrome mice using NLX-101, a selective 5-HT1A receptor biased agonist
Open Access
- 23 March 2025
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 186, 117989
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e a Tecnologia (UIDB/50026/2020)
- International Rett Syndrome Foundation
This publication has 63 references indexed in Scilit:
- Trofinetide: First ApprovalDrugs, 2023
- Breathing disturbances in Rett syndrome2022
- The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stressPsychopharmacology, 2021
- Drug Studies on Rett Syndrome: From Bench to BedsideJournal of Autism and Developmental Disorders, 2020
- Chronic Treatment with 17-DMAG Improves Balance and Coordination in A New Mouse Model of Machado-Joseph DiseaseNeurotherapeutics, 2014
- Rett syndrome: Revised diagnostic criteria and nomenclatureAnnals of Neurology, 2010
- Mouse behavioral tasks relevant to autism: Phenotypes of 10 inbred strainsBehavioural Brain Research, 2007
- Buspirone in Rett syndrome respiratory dysfunctionBrain and Development, 2005
- Rett syndrome: Biogenic amines and metabolites in postmortem brainPediatric Neurology, 1989
- Cerebrospinal fluid biogenic amines and biopterin in rett syndromeAnnals of Neurology, 1989